Meeting Global Challenges German-U.S. Innovation Policy: Summary of a Symposium (2012) / Chapter Skim
Currently Skimming:
Panel IX: Medical/Biomedical Innovation for the 21st Century
Panel IX: Medical/Biomedical Innovation for the 21st Century
Pages 147-153
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 147... ...
Giesekus. The National Cancer Institute was long renowned for its basic research in biomedicine, while the structure and success of the Fraunhofer program had been for some years a topic of growing interest to the U.S.
|
From page 148... ...
In addition, he said, it was "possibly the most exciting time to be doing biomedical research." In 2001, the full sequencing of the human genome was completed, and last year investigators in the United States, in collaboration with partners elsewhere, launched the 1000 Genomes Project to examine gene-bygene population differences. These and other programs have generated unprecedented amounts of information that is being put into public domain.
|
From page 149... ...
Finding an Unanticipated Innovation When his group first showed their paper, fully characterizing the brain disease, they reported a few unanticipated "innovations": a possible resistance mechanism inside this disease, discernible only because they were able to review 400 to 500 patient samples. That became a reference set, in 2009, and other investigators compared it to their own data sets.
|
From page 150... ...
In 2004 the center published the first nanotech plan solely directed at clinical utility. Others had used nanotech for basic biology, "but this one was different." In the first phase, launched in 2007, the center was able to develop about 50 companies through SBIR awards and other mechanisms, file over 200 patents, and start eight to 10 clinical trials from the nanoplatform.
|
From page 151... ...
This talk is about how we get basic research results into the market for the medical device industry." For the past decade, for example, the institute has studied an ultra stereoscopic 3D display that can be used without eyeglasses. It depends on the ability of the display screen to detect the position of each eye and alter the pixels on the display accordingly; this allows the eyes to perceive a large "sweet spot" and optimal depth "This is something we can use to show a patient an image in the field of medicine." In a second example, the HHI collaborates with the Berlin Philharmonic and an automotive industry partner to create immersive media platform with high resolution audio, video, and 3D.
|
From page 152... ...
Dr. Giesekus mentioned several other technologies with possible medical applications, including optical sensing at the nanoscale to identify dangerous bacteria or explosives; tiny fiber sensors, now used to measure stress and strain in a building, to control the position of a colonoscope or other instrument; cheap, handheld terahertz imaging devices to detect cancers, cavities in teeth, explosives, or other abnormalities.
|
From page 153... ...
"We are always looking for industry partners and research institutes," he said, "where our technology from telecommunications can be applied to other uses." DISCUSSION Ambassador Murphy asked the speakers how they were able to select new areas for application of existing technologies.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.